Affiliation: Stanford University School of Medicine, Stanford Cardiovascular Institute

Dr. Ebrahim Mostafavi, PhD is currently at the Stanford Cardiovascular Institute, Stanford School of Medicine. His research interests revolve around the use of cardiac iPS cells to design and develop in vitro models (organoids, 3D bioprinted constructs, vascular grafts) for cardiovascular disease modeling and drug screening, as well as CRISPR/Cas gene-editing for cardiovascular diseases. Dr. Mostafavi received his PhD in Chemical Engineering (with a focus on Biomedical Engineering and Regenerative Medicine) from Northeastern University, Boston, MA. During his doctoral training, he received several prestigious awards. He has also received training at Harvard Medical School/Brigham and Women's Hospital on engineering and development of (nano)biomaterials and 3D scaffolds (hydrogels, 3D bioprinted constructs, and nanoporous scaffolds) to create biologically complex tissues and organs for tissue engineering, regenerative medicine, and translational applications. His scholarly work consists of > 70 publications with an H-index of 22 (i10-index= 35) on Google Scholar Profile. He currently serves as the Associate Editor-in-Chief of the International Journal of Nanomedicine (IF=6.4, Q1) at Dove Medical Press/T&F, and Associate Editor of Frontiers in Nanotechnology-Biomedical Nanotechnology. He is also an Editorial Board Member of several biomedical and materials engineering journals, including, Nature Scientific Reports, Springer Nature Journal of Nanostructure in Chemistry, MDPI Cells, MDPI Journal of Functional Biomaterials, BMC Biotechnology, BMC Biomedical Engineering, Current Medicinal Chemistry, etc. He also contributed to more than 15 book chapters and was selected as the editor of several books.